Central Pacific Bank - Trust Division’s Maravai LifeSciences MRVI Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-235	Closed	-$665	–	911
2026 Q1	$665	Hold	235	–	–	﹤0.01%	840
2025 Q4	$764	Hold	235	–	–	﹤0.01%	820
2025 Q3	$674	Hold	235	–	–	﹤0.01%	815
2025 Q2	$566	Hold	235	–	–	﹤0.01%	825
2025 Q1	$519	Hold	235	–	–	﹤0.01%	832
2024 Q4	$1.28K	Sell	235 -300	-56%	-$1.93K	﹤0.01%	839
2024 Q3	$4.45K	Hold	535	–	–	﹤0.01%	753
2024 Q2	$3.83K	Hold	535	–	–	﹤0.01%	838
2024 Q1	$4.6K	Buy	+535	New	+$3.62K	﹤0.01%	829

Other funds holding MRVI

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

DRP

Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return

Central Pacific Bank - Trust Division's MRVI Position: Q2 2026 in Review

Central Pacific Bank - Trust Division sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 235 shares — an estimated $665 sold.

Central Pacific Bank - Trust Division first reported a position in MRVI in Q1 2024 and held it in 9 quarters. The position peaked at $4.6K in Q1 2024. 21 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Central Pacific Bank - Trust Division reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
Central Pacific Bank - Trust Division sold 235 Maravai LifeSciences shares in Q2 2026, an estimated $665.
Central Pacific Bank - Trust Division first reported a position in Maravai LifeSciences in Q1 2024 and held it in 9 quarters.
Central Pacific Bank - Trust Division's Maravai LifeSciences position peaked at $4.6K in Q1 2024.
21 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.